UBS Group’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.9M Sell
469,257
-122,775
-21% -$6.67M 0.01% 1999
2026
Q1
$22.8M Buy
592,032
+235,331
+66% +$9.78M ﹤0.01% 2443
2025
Q4
$16.6M Buy
356,701
+223,980
+169% +$10.8M ﹤0.01% 2763
2025
Q3
$6.51M Buy
132,721
+97,421
+276% +$5.1M ﹤0.01% 3766
2025
Q2
$1.83M Buy
+35,300
New +$1.43M ﹤0.01% 4917

Other funds holding HNGE

UBS Group's HNGE Position: Q2 2026 in Review

UBS Group reduced its Hinge Health (HNGE) stake by 21% in Q2 2026, selling an estimated $6.67M and leaving 469,257 shares worth $38.9M. The position accounts for 0.01% of the portfolio, ranked #1999.

UBS Group first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • UBS Group held 469,257 shares of Hinge Health worth $38.9M as of Q2 2026.
  • UBS Group sold 122,775 Hinge Health shares in Q2 2026, an estimated $6.67M.
  • Hinge Health made up 0.01% of UBS Group's portfolio in Q2 2026, its #1999 holding.
  • UBS Group first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.